Strengths and Weaknesses of Diagnostic Tools for Tuberculous Uveitis
Authors:
- 15 October 2009
- journal article
- research article
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 17 (5) , 351-355
Abstract
Diagnostic criteria for tuberculous uveitis encompass exclusion of other known etiologies of uveitis, suggestive clinical history and signs, supportive systemic investigations, positive response to empiric antituberculosis treatment and evidence of Mycobacterium tuberculosis or its DNA in ocular fluids/tissues. Recent advances in diagnostic tools for tuberculous infection, including molecular biology techniques for detection of M. tuberculosis DNA and interferon-gamma release assays, have improved the specificity of the diagnosis and the ability to ascertain exposure to the infectious agent. However even with such advances, establishing the diagnosis of tuberculous uveitis remains a challenging issue because each of these available investigations has its strengths and limitations and tuberculous infection can present with clinical features of any type of extraocular or intraocular inflammation. This article critically analyzes the role of these tests in supporting the diagnosis of tuberculous uveitis and proposes a practical diagnostic approach, based on a judicious combination of these tests.Keywords
This publication has 30 references indexed in Scilit:
- QuantiFERON TB-Gold—A New Test Strengthening Long-Suspected Tuberculous Involvement in Serpiginous-like ChoroiditisAmerican Journal of Ophthalmology, 2008
- Interferon-γ Release Assays in the Diagnosis of Tuberculous UveitisAmerican Journal of Ophthalmology, 2008
- Intraocular Tuberculosis—An UpdateSurvey of Ophthalmology, 2007
- Prevalence of Abnormal Radiological Findings in Health Care Workers with Latent Tuberculosis Infection and Correlations with T Cell Immune ResponsePLOS ONE, 2007
- Is Adipose Tissue a Place for Mycobacterium tuberculosis Persistence?PLOS ONE, 2006
- Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factorNature Clinical Practice Rheumatology, 2006
- Adverse reactions to first-line antituberculosis drugsExpert Opinion on Drug Safety, 2006
- Adaptive immunity to mycobacteriaCurrent Opinion in Microbiology, 2004
- INTRAOCULAR TUBERCULOSISRetina, 1995
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989